Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Very well put. Speed bumps are to be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jimmy667 Member Profile
 
Followed By 85
Posts 5,131
Boards Moderated 0
Alias Born 10/20/15
160x600 placeholder
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/20/2021 9:31:05 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/17/2021 5:24:23 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/10/2021 4:05:53 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/7/2021 1:49:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 6:06:41 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/3/2021 6:04:42 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/2/2021 6:03:28 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/31/2021 4:56:35 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/31/2021 2:09:30 PM
CEO Presenting on the Emerging Growth Conference on September 1.  Register Now InvestorsHub NewsWire - 8/30/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on September 1.  Register Now InvestorsHub NewsWire - 8/30/2021 7:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/26/2021 5:19:44 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/25/2021 8:18:51 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/25/2021 8:11:48 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/19/2021 4:49:51 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/19/2021 8:13:24 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/18/2021 5:17:11 PM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 8/18/2021 2:17:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 5:27:55 PM
Proxy Soliciting Materials (revised) (prrn14a) Edgar (US Regulatory) - 8/13/2021 6:08:30 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/13/2021 6:05:07 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 8/12/2021 6:05:07 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2021 6:50:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2021 6:40:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2021 6:20:32 PM
jimmy667   Wednesday, 05/19/21 04:28:14 PM
Re: Mister Money post# 166594
Post # of 184880 
Very well put. Speed bumps are to be expected in pre-revenue biotech. That is all the FDA letter was a speed bump with an admonishion to slow down and generate more data. That is what will happen in the 4 dose Brazil trial run by a top notch world class CRO. If those trial pan out CYDY might 5x or 10x from here as early as August or September.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences